National Institutes of Health — Bethesda, Maryland

Public research footprint of National Institutes of Health, compiled from the ClinicalTrials.gov public registry.

3,371

Registered studies

839

Active

612

Recruiting now

1,984

Completed

535

Stopped or withdrawn

Most-studied conditions

Recurrent Abdominal Adrenocortical Carcinoma (ACC) · PASC Post Acute Sequelae of COVID-19 · Relapsed and/or Refractory Multiple Myeloma (RRMM) · Extensive-Stage Small Cell Lung Cancer

Recently updated registry entries

NCT07388550 — Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of… (Not Yet Recruiting)
NCT00923026 — Follow Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies (Enrolling By Invitation)
NCT06577467 — Cross-Sectional Evaluation of Persistence of SARS-CoV-2 Remnants After Recovery From… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at National Institutes of Health?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.